NEW YORK, N.Y., USA: The anesthetic drug midazolam is in widespread use for brief dental and medical procedures due to its sedative and amnestic properties. However, cardiorespiratory depression can occur when it is given in higher doses or repeatedly to achieve deeper levels of sedation. A new study tests the ability of an added drug, adenosine 5′-triphosate (ATP), to safely achieve these deeper levels of anesthesia.
The journal Anesthesia Progress recently reported results of a study of 10 healthy volunteers who underwent two anesthetic experiments at least two weeks apart. In one session, the volunteers received intravenous bolus administration of midazolam followed by a continuous infusion of ATP for 40 minutes. In the other session, the patients received a placebo infusion of saline after the midazolam.
The patients were monitored for 60 minutes. Changes in systolic blood pressure, heart rate, respiratory rate and other cardiorespiratory measures were recorded every five minutes. Bispectral index (BIS) was used to evaluate the depth of anesthesia the patients experienced.
BIS analyzes electroencephalogram (EEG) patterns to continuously assess the depth of sedation. The patients’ consciousness was evaluated by their response to verbal commands such as “squeeze my fingers” and “open your eyes.” These parameters showed a deeper level of sedation for the use of midazolam plus ATP.
Under midazolam alone, patients showed a BIS value that went from 97 (±1) prior to administration to 68 (±18) after 25 minutes. The volunteers remained conscious but showed signs of significant cardiopulmonary depressant effects. However, following 15 to 30 minutes of coadministration of ATP, no adverse cardiorespiratory effects were seen and patients became unconscious. The BIS value further reduced to 51 (±13) after receiving ATP.
No adverse effects such as hypotension, chest pains, headache, nausea, or vomiting were seen. The authors concluded that the addition of ATP significantly enhances the sedation effect of midazolam with improved cardiorespiratory functions.
Anesthesia Progress is the official publication of the American Dental Society of Anesthesiology (ADSA). The quarterly journal is dedicated to providing a better understanding of the advances being made in the science of pain and anxiety control in dentistry. The journal invites submissions of review articles, reports on clinical techniques, case reports, and conference summaries.
(Source: Anesthesia Progress)
NEW YORK, N.Y., USA: In response to the American Dental Association’s urgings for assistance in addressing the opioid abuse crisis, Dr. Bernard ...
MELVILLE, N.Y., USA: Henry Schein Cares, the global corporate social responsibility program of Henry Schein Inc., and Alpha Omega International Dental ...
CHICAGO, Ill., USA: The Chicago Dental Society’s 2017 Midwinter Meeting offered plenty of educational opportunities, not only in the lecture halls but...
NEW YORK, N.Y., USA: An improvement may be in order for the most common dental anesthetic. The inferior alveolar nerve block is the most commonly used form ...
By far the most frequently asked question in every orthodontic office is, “When are my braces coming off?” In the fast-paced, busy lives of ...
I invented the Continuous Wave of Obturation Technique (CWOT) in 1986 and used it with the Touch’n Heat (SybronEndo) until the winter season of ...
One of the many difficult decisions you will face on a daily basis is how to achieve long-term retention when the patient is out of your control. Reliance ...
Nearly 28,000 dental professionals and guests from across the U.S. are expected at what organizers describe the as New England’s largest dental ...
MELVILLE, N.Y., USA Henry Schein Inc. is celebrating Earth Day 2015 by offering its customers the opportunity to purchase “green” products ...
In September 2009, Oral Science introduced Cetacaine, a non-injectable topical anesthetic well-suited to controlling pain of scaling and root planing, ...
Live webinar
Thu. 18 July 2024
8:00 PM EST (New York)
Live webinar
Fri. 26 July 2024
11:00 AM EST (New York)
Live webinar
Tue. 6 August 2024
6:00 PM EST (New York)
Live webinar
Tue. 13 August 2024
7:00 PM EST (New York)
Live webinar
Wed. 14 August 2024
12:30 PM EST (New York)
Live webinar
Wed. 21 August 2024
9:00 AM EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Thu. 22 August 2024
4:00 PM EST (New York)
To post a reply please login or register